Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system
Nucleic Acids Research · 11.12.2023 · 51 (22) · 12381-12396
DOI: 10.1093/nar/gkad995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 01.11.2023. Verfasst von Guoxu Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Hauptthemen laut MEDLINE: CRISPR-Associated Protein 9, CRISPR-Cas Systems. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Biological Resources Program of Chinese Academy of Sciences.
Abstract (Originalsprache)
Anti-CRISPR (Acr) proteins are encoded by mobile genetic elements to overcome the CRISPR immunity of prokaryotes, displaying promises as controllable tools for modulating CRISPR-based applications. However, characterizing novel anti-CRISPR proteins and exploiting Acr-related technologies is a rather long and tedious process. Here, we established a versatile plasmid interference with CRISPR interference (PICI) system in Escherichia coli for rapidly characterizing Acrs and developing Acr-based technologies. Utilizing the PICI system, we discovered two novel type II-A Acrs (AcrIIA33 and AcrIIA34), which can inhibit the activity of SpyCas9 by affecting DNA recognition of Cas9. We further constructed a circularly permuted AcrIIA4 (cpA4) protein and developed optogenetically engineered, robust AcrIIA4 (OPERA4) variants by combining cpA4 with the light-oxygen-voltage 2 (LOV2) blue light sensory domain. OPERA4 variants are robust light-dependent tools for controlling the activity of SpyCas9 by approximately 1000-fold change under switching dark-light conditions in prokaryotes. OPERA4 variants can achieve potent light-controllable genome editing in human cells as well. Together, our work provides a versatile screening system for characterizing Acrs and developing the Acr-based controllable tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- CAS Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Yong Tian
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Biological Resources Program of Chinese Academy of Sciences
- Young Elite Scientist Sponsorship Program
Zitieren
APA
Song, G., Tian, C., Li, J., Zhang, F., Peng, Y., Gao, X., & Tian, Y. (2023). Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system. Nucleic Acids Research, 51(22), 12381-12396. https://doi.org/10.1093/nar/gkad995
Vancouver
Song G, Tian C, Li J, Zhang F, Peng Y, Gao X, et al. Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system. Nucleic Acids Research. 2023;51(22):12381-12396. doi:10.1093/nar/gkad995
BibTeX
@article{Song2023,
author = {Song, Guoxu and Tian, Chunhong and Li, Jiahui and Zhang, Fei and Peng, Yuxin and Gao, Xing and Tian, Yong},
title = {Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {22},
pages = {12381--12396},
doi = {10.1093/nar/gkad995}
}
EUVIMED